BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.270
-0.030 (-1.30%)
At close: Apr 24, 2026, 4:00 PM EDT
2.290
+0.020 (0.88%)
After-hours: Apr 24, 2026, 7:08 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $11.36 million as of April 24, 2026. Its market cap has decreased by -10.84% in one year.
Market Cap
11.36M
Enterprise Value
5.41M
1-Year Change
-10.84%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $11.36M, a decrease of -66.39%. That is a compound annual growth rate of -6.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 11.36M | -13.31% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 12.43M |
| Traws Pharma | 11.78M |
| Cellectar Biosciences | 11.70M |
| Chemomab Therapeutics | 11.59M |
| Reviva Pharmaceuticals Holdings | 11.53M |
| BioVie | 11.31M |
| CytoMed Therapeutics | 11.25M |
| Lunai Bioworks | 11.25M |